C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
CLVRR Equity

CLVRR

OTCMKTS · CLVRR

$0.00
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
38/100 composite
Fundamentals31
Regulatory50
Market40
Editorial30
Composite · trailing 12 months

Clever Leaves has been rated Neutral with a band defined by moderate conviction, placed at a 3 out of 5 score. The rating is primarily driven by the company's regulatory standing, where it scores well, marking it as the strongest pillar in the overall assessment. This strength in compliance and regulatory positioning offsets the weaker performance seen in the fundamentals and editorial exposure, contributing to the composite score of 37.9. The market pillar remains minimally analyzed due to the absence of quoted data, leaving it less informative in the current evaluation.

Underlying financial metrics reveal several areas of concern, most notably with revenue growth and margins. Clever Leaves has experienced a modest year-over-year revenue increase, yet it suffers from a severely negative operating margin, signaling operational inefficiencies. Despite achieving a positive gross margin, the net income remains submerged in red, amplified by a stretched cash condition marked by significant burn rates. Primary regulatory filings and licensed fundamentals data provide insights suggesting limited flexibility, with the financial condition reflecting a comprehensive cautionary note.

Looking ahead, the company's activities within the Latin American regulatory environment serve as the crucial catalyst. The jurisdictional stance in this region, supported by a non-existent enforcement history over recent periods, underpins professional confidence in its regulatory path forward. Observers should focus on any shifts in regulation within these jurisdictions, as these will have a material impact on Clever Leaves’ future capabilities and potential for growth within the cannabis sector. Monitoring upcoming filings and regulatory developments will be essential to understanding potential shifts in the Neutral rating position.

Scored: 2026-08-24Valid through: 2026-10-08Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Phone
+1-201-565-3345
CEO
Andres Fajardo
CFO
Henry R. Hague III (Hank Hague)
SEC CIK
0001819615
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$0.0M
Enterprise value
$-4.7M
EV / EBITDA
-0.07
Revenue (TTM)
$17.4M
Gross profit (TTM)
$6.6M
EBITDA
$-13.2M
Operating margin
-105.9%
Profit margin
-102.8%
Rev growth YoY
5.4%
Return on equity
-61.3%
Return on assets
-23.4%
EPS (TTM)
$-2.11
Wall St. target price
$24.00
Shares outstanding
1.8M
Beta
1735.91
Full-time employees
296
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for CLVRR (CLVRR)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for CLVRR (CLVRR), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for CLVRR are maintained by Cannabis Investor News and refreshed throughout the trading day.